Insulin icodec

Awiqli is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Prescribing label

Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗

Drug facts

Used for: Awiqli is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Do not take if: During episodes of hypoglycemia.
In patients with hypersensitivity to insulin icodec-abae or any of the excipients in Awiqli FlexTouch. Serious hypersensitivity reactions have included anaphylaxis.

Side effects, and when to stop

The following adverse reactions are also discussed elsewhere:

Hypoglycemia Due to Medication Errors and Accidental Overdose
Hypoglycemia
Hypersensitivity reactions
Hypokalemia

Who should not take it

Awiqli is contraindicated:

During episodes of hypoglycemia.
In patients with hypersensitivity to insulin icodec-abae or any of the excipients in Awiqli FlexTouch. Serious hypersensitivity reactions have included anaphylaxis.

Other medicines and interactions

Table 3 includes clinically significant drug interactions with Awiqli.

Table 3: Clinically Significant Drug Interactions with Awiqli

Cite this page

NLM: sofidex [Internet]. Daloreum; c2026. Insulin icodec; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/insulin-icodec
APA 7th: sofidex. (2026, August 3). Insulin icodec. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/insulin-icodec
AMA 11th: Insulin icodec. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/insulin-icodec

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.